Literature DB >> 18321179

The prevalence of cervical HPV and cytological abnormalities in association with reproductive factors of rural Nigerian women.

Peter F Schnatz1, Natalia V Markelova, Danielle Holmes, Srinivas R Mandavilli, David M O'Sullivan.   

Abstract

OBJECTIVE: To estimate the prevalence of cervical human papillomavirus (HPV) and cytological abnormalities while addressing demographic and reproductive variables in a sample of rural Nigerian patients.
METHODS: In March 2004, a medical project was conducted in Okene, Nigeria. The obstetrics/gynecology team collected demographics of 231 patients and 199 ThinPrep Pap smears (Cytyc, Marlborough, MA), which were analyzed cytologically and for the presence of HPV DNA.
RESULTS: Of 231 patients (mean age 32.2), 76% had seen a physician four times or less. From 199 Pap smears performed, 21.6% had high-risk (HR) HPV, low-risk (LR) HPV, or both. HR HPV was present in 16.6% of the women. There were 13 (6.5%) abnormal Pap smears, of which 9 (4.5%) had atypical squamous cells of undetermined significance (ASCUS), 1 (0.5%) had atypical glandular cells (AGC), 2 (1%) had low-grade squamous intraepithelial lesions (LSIL), and 1 (0.5%) had a high-grade SIL (HSIL). Other findings were Trichomonas vaginalis in 18 patients (9%) and Candida in 27 patients (13.5%).
CONCLUSIONS: The prevalence of cervical HPV and SIL in Okene, Nigeria, is consistent with reports from other African regions. Improved access to healthcare and cervical cancer screening programs may help to decrease transmission of HPV and subsequent cervical cancer in underprivileged areas.

Entities:  

Mesh:

Year:  2008        PMID: 18321179     DOI: 10.1089/jwh.2006.0295

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  12 in total

Review 1.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

Authors:  Hugo De Vuyst; Laia Alemany; Charles Lacey; Carla J Chibwesha; Vikrant Sahasrabuddhe; Cecily Banura; Lynette Denny; Groesbeck P Parham
Journal:  Vaccine       Date:  2013-12-29       Impact factor: 3.641

2.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

Review 3.  Challenges in treating malignancies in HIV in Nigeria.

Authors:  Oluyemisi Akinwande; Temidayo Ogundiran; Sally Akarolo-Anthony; Ibrahim Mamadu; Patrick Dakum; William Blattner; Clement Adebamowo
Journal:  Curr Opin Oncol       Date:  2009-09       Impact factor: 3.645

4.  Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus.

Authors:  Ana Cristina Macêdo Barcelos; Márcia Antoniazi Michelin; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-29

5.  Screening Cervical Cancer by the Pap Test – Relevance of Age Ranges Recommended by the Brazilian Programme for Prevention and Control

Authors:  Diogo Do Nascimento Franco; Adriana Cunha Vargas Tomáz; Angela Andréia Franca Gravena; Sandra Marisa Pelloso; Márcia Edilaine Lopes Consolaro
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

6.  Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria.

Authors:  Yewande T Nejo; David O Olaleye; Georgina N Odaibo
Journal:  PLoS One       Date:  2019-11-04       Impact factor: 3.240

7.  The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019: a systematic review.

Authors:  Anthony Uchenna Emeribe; Idris Nasir Abdullahi; Maisie Henrietta Etukudo; Idongesit Kokoabasi Isong; Anthony Ogbonna Emeribe; Justin Onyebuchi Nwofe; Chikodi Modesta Umeozuru; Buhari Isa Shuaib; Odunayo Rahmat Oyetola Ajagbe; Amos Dangana; Bibiana Nonye Egenti; Peter Elisha Ghamba
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 8.  Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination.

Authors:  Ivan Branković; Petra Verdonk; Ineke Klinge
Journal:  Int J Equity Health       Date:  2013-02-08

9.  Perceptions of Nigerian Women about Human Papilloma Virus, Cervical Cancer, and HPV Vaccine.

Authors:  Olusola Anuoluwapo Akanbi; Abiodun Iyanda; Folakemi Osundare; Oluyinka Oladele Opaleye
Journal:  Scientifica (Cairo)       Date:  2015-10-13

10.  Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria.

Authors:  Nyengidiki Tamunomie Kennedy; Durugbo Ikechukwu; Bassey Goddy
Journal:  Pan Afr Med J       Date:  2016-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.